All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.
During the SOHO 2022 Annual Meeting, the Lymphoma Hub spoke with Won Seog Kim, Sungkyunkwan University, Seoul, KR. We asked, What are the latest advances in the treatment of NK/T-cell lymphoma?
What are the latest advances in the treatment of NK/T-cell lymphoma?
Kim discusses current treatment options for NK/T-cell lymphoma, including the appropriate use of chemotherapy, radiation, and checkpoint inhibitors, and when they should be combined.
Understanding your specialty helps us to deliver the most relevant and engaging content.
Please spare a moment to share yours.
Please select or type your specialty
Treating classical Hodgkin lymphoma that is refractory to salvage chemotherapy
As part of our biannual steering committee meeting, Astrid Pavlovsky, Fundaleu, Beunos Aires, AR, chaired a case study discussion session on treating a patient with...
Educational theme: Advances in T-cell lymphomas
Throughout May, the Lymphoma Hub will be focusing on a new educational theme of “Advances in T-cell lymphomas”. This article introduces the topic of T-cell lymphomas and summarizes some of the latest...
Subscribe to get the best content related to lymphoma & CLL delivered to your inbox